For Surest's preventive care programs, should we emphasize increasing utilization rates or focus on measuring and improving long-term health outcomes for participants?

Introduction

The trade-off we're examining today is whether Surest's preventive care programs should prioritize increasing utilization rates or focus on measuring and improving long-term health outcomes for participants. This decision is crucial for the company's strategic direction and impact on user health. I'll analyze this trade-off by exploring key metrics, experiment design, and potential outcomes to provide a comprehensive recommendation.

Step 1

Clarifying Questions (3 minutes)

• Based on the current healthcare landscape, I'm thinking cost-effectiveness might be a key driver. Could you share more about Surest's revenue model and how it relates to preventive care programs?

Why it matters: Helps understand financial incentives and sustainability of different approaches. Expected answer: Value-based care model with shared savings for improved outcomes. Impact on approach: Would emphasize long-term health outcomes if aligned with financial incentives.

• Considering user engagement patterns, I'm curious about the current utilization rates. What percentage of eligible users are actively participating in preventive care programs?

Why it matters: Establishes a baseline for improvement and identifies potential engagement issues. Expected answer: Moderate utilization around 40-50% with room for improvement. Impact on approach: Low utilization would prioritize increasing participation before focusing on outcomes.

• Looking at technical capabilities, I'm wondering about our data collection and analysis infrastructure. How robust is our system for tracking long-term health outcomes?

Why it matters: Determines feasibility of measuring and improving long-term outcomes. Expected answer: Basic systems in place, but room for improvement in longitudinal tracking. Impact on approach: Limited capabilities might necessitate a focus on more immediate, measurable metrics.

• Considering resource allocation, I'm thinking about our team's capacity. Do we have dedicated resources for both increasing utilization and measuring long-term outcomes?

Why it matters: Helps determine if we can pursue both strategies simultaneously or need to choose. Expected answer: Limited resources, requiring prioritization of efforts. Impact on approach: Resource constraints might force a more focused strategy on one aspect.

• Given the evolving healthcare landscape, I'm curious about any regulatory pressures or industry trends. Are there any upcoming changes that might impact our decision?

Why it matters: Ensures our strategy aligns with external factors and future requirements. Expected answer: Increasing emphasis on value-based care and outcomes reporting. Impact on approach: Would lean towards long-term outcome focus if aligned with industry direction.